TW513415B - 4-aminoalkoxy-1H-benzoimidazoles having dopamine D2 agonist activity and pharmaceutical composition thereof - Google Patents
4-aminoalkoxy-1H-benzoimidazoles having dopamine D2 agonist activity and pharmaceutical composition thereof Download PDFInfo
- Publication number
- TW513415B TW513415B TW087101275A TW87101275A TW513415B TW 513415 B TW513415 B TW 513415B TW 087101275 A TW087101275 A TW 087101275A TW 87101275 A TW87101275 A TW 87101275A TW 513415 B TW513415 B TW 513415B
- Authority
- TW
- Taiwan
- Prior art keywords
- scope
- amine
- patent application
- ethyl
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/10—Radicals substituted by halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US80127697A | 1997-02-18 | 1997-02-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW513415B true TW513415B (en) | 2002-12-11 |
Family
ID=25180658
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW087101275A TW513415B (en) | 1997-02-18 | 1998-02-03 | 4-aminoalkoxy-1H-benzoimidazoles having dopamine D2 agonist activity and pharmaceutical composition thereof |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0973749A1 (es) |
JP (1) | JP2001509814A (es) |
KR (1) | KR20000071129A (es) |
CN (1) | CN1252793A (es) |
AR (1) | AR011136A1 (es) |
AU (1) | AU746717B2 (es) |
BR (1) | BR9807701A (es) |
CA (1) | CA2278700A1 (es) |
HU (1) | HUP0001302A3 (es) |
IL (1) | IL131158A0 (es) |
NZ (1) | NZ336969A (es) |
TW (1) | TW513415B (es) |
WO (1) | WO1998035945A1 (es) |
ZA (1) | ZA981309B (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6541502B1 (en) * | 2001-07-20 | 2003-04-01 | Wyeth | 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]-naphthalenyl derivatives with antipsychotic activity |
WO2003075921A2 (en) * | 2002-03-05 | 2003-09-18 | Transtech Pharma, Inc. | Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage |
ES2467923T3 (es) | 2009-09-30 | 2014-06-13 | Transtech Pharma, Llc | Derivados de imidazol substituidos para el tratamiento de la enfermedad de Alzheimer |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4704390A (en) * | 1986-02-13 | 1987-11-03 | Warner-Lambert Company | Phenyl and heterocyclic tetrahydropyridyl alkoxy-benzheterocyclic compounds as antipsychotic agents |
ES2169102T3 (es) * | 1994-10-14 | 2002-07-01 | Merck Patent Gmbh | (r)-(-)-2-(5-(4-fluorfenil)-3-piridilmetilaminometil)-cromano como agente activo sobre el sistema nervioso central. |
ZA9610745B (en) * | 1995-12-22 | 1997-06-24 | Warner Lambert Co | 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
ATE234281T1 (de) * | 1996-08-27 | 2003-03-15 | Wyeth Corp | 4-aminoethoxy-indolderivate als dopamin d2 agonisten und als 5ht1a liganden |
-
1998
- 1998-01-13 NZ NZ336969A patent/NZ336969A/xx unknown
- 1998-01-13 KR KR1019997007418A patent/KR20000071129A/ko not_active Application Discontinuation
- 1998-01-13 CA CA002278700A patent/CA2278700A1/en not_active Abandoned
- 1998-01-13 EP EP98902513A patent/EP0973749A1/en not_active Withdrawn
- 1998-01-13 AU AU59153/98A patent/AU746717B2/en not_active Ceased
- 1998-01-13 WO PCT/US1998/000613 patent/WO1998035945A1/en not_active Application Discontinuation
- 1998-01-13 BR BR9807701-5A patent/BR9807701A/pt not_active IP Right Cessation
- 1998-01-13 IL IL13115898A patent/IL131158A0/xx unknown
- 1998-01-13 HU HU0001302A patent/HUP0001302A3/hu unknown
- 1998-01-13 JP JP53572798A patent/JP2001509814A/ja active Pending
- 1998-01-13 CN CN98804249A patent/CN1252793A/zh active Pending
- 1998-02-03 TW TW087101275A patent/TW513415B/zh active
- 1998-02-11 AR ARP980100617A patent/AR011136A1/es not_active Application Discontinuation
- 1998-02-17 ZA ZA9801309A patent/ZA981309B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
ZA981309B (en) | 1999-08-17 |
HUP0001302A3 (en) | 2001-07-30 |
BR9807701A (pt) | 2000-05-02 |
CA2278700A1 (en) | 1998-08-20 |
HUP0001302A2 (hu) | 2001-05-28 |
IL131158A0 (en) | 2001-01-28 |
JP2001509814A (ja) | 2001-07-24 |
EP0973749A1 (en) | 2000-01-26 |
AR011136A1 (es) | 2000-08-02 |
KR20000071129A (ko) | 2000-11-25 |
WO1998035945A1 (en) | 1998-08-20 |
AU5915398A (en) | 1998-09-08 |
CN1252793A (zh) | 2000-05-10 |
AU746717B2 (en) | 2002-05-02 |
NZ336969A (en) | 2001-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5952917B2 (ja) | ベンゾチオフェン化合物又はその塩の、二水和物、及びその製造方法 | |
CA2280447C (en) | Pyrrolo¬1,2-a|pyrazine derivatives as 5ht1a ligands | |
JP5501230B2 (ja) | セロトニン5−ht6受容体の調節に応答する障害の治療に好適なキノリン化合物 | |
CN109311843A (zh) | 作为PI3Kβ抑制剂的氮杂苯并咪唑衍生物 | |
CN102015720A (zh) | 神经元烟碱性受体的选择性配体及其应用 | |
JP2011516598A (ja) | ニコチン性アセチルコリン受容体サブタイプアルファ−71のモジュレータとしてのインドール | |
PL188330B1 (pl) | Dihydrat metanosulfonianu 5-{2-[4-(1,2-benzizotiazol-3-ilo)-1-piperazynylo]etylo}-6-chloro-1,3-dihydro-2H-indol-2-onu i środek farmaceutyczny | |
JP2003527374A (ja) | 1,2,3,4−テトラヒドロイソキノリン誘導体 | |
PL188164B1 (pl) | Trihydrat metanosulfonianu 5-{2-[4-1,2-benzizotiazol-3-ilo)-1-piperazynylo]etylo}-6-chloro-1,3-dihydro-2H-indol-2-onu i środek farmaceutyczny | |
TW201035055A (en) | Substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds | |
JP2005530763A (ja) | カリウム・チャネル調節物質としてのビス−ベンズイミダゾール及び関連化合物 | |
TW202140467A (zh) | 小分子干擾素基因刺激因子(sting)拮抗劑 | |
MX2007002732A (es) | Ligandos de difenil eter terapeuticos. | |
AU2017208119B2 (en) | 6,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine dopamine D3 ligands | |
AU775093B2 (en) | 2,7-substituted octahydro-1H-pyrido(1,2-a)pyrazine derivatives as ligands for serotonin receptors | |
TW513415B (en) | 4-aminoalkoxy-1H-benzoimidazoles having dopamine D2 agonist activity and pharmaceutical composition thereof | |
TW589315B (en) | 1,2,3,4-tetrahydro-benzofuro[3,2-c]pyridine derivatives | |
JP7390401B2 (ja) | 縮合環化合物、その製造方法及び用途 | |
EP2718290A2 (en) | Compositions and methods for modulating a kinase | |
AU2018305223A1 (en) | New propanamine derivatives for treating pain and pain related conditions | |
TW202043209A (zh) | Mek抑制劑及其在醫藥上的應用 | |
DE60005685T2 (de) | Oxazinocarbazole zur behandlung von cns-erkrankungen | |
JPH09512025A (ja) | 5ht▲下2c▼および5ht▲下2b▼アンタゴニストとしての三環式誘導体 | |
CN1277607A (zh) | 2-取代的1,2-苯并异噻唑衍生物及其作为血清素拮抗剂(5-ht1a,5-ht1b和5-ht1d)的应用 | |
PT1645558E (pt) | Piperazinilpirazinas como moduladores do receptor 5-ht2c da serotonina |